Improve working memory and planning
- Trial ID
- NCT04229056
- Official Title
- Computer-Assisted Self-Training to Improve Executive Function Versus Unspecific Training in Patients After Stroke, Cardiac Arrest or in Parkinson's Disease: a Randomized Controlled Trial
- Goal
- Improve working memory and planning
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Bispebjerg Hospital
- Study Type
- INTERVENTIONAL
- Enrollment
- 307 participants
- Conditions
- Parkinson Disease, Stroke, Cardiac Arrest, Cognitive Dysfunction, Executive Dysfunction
- Interventions
- Computer-based cognitive rehabilitation (CBCR), General computer-based cognitive stimulation
Plain-Language Summary
The goal is to boost executive skills, especially working memory and everyday planning, that often decline in Parkinson's and cause real-life problems with thinking and multitasking. The approach is computer-assisted self-training made of repeated, adaptive exercises that target working memory, attention, and planning, compared with unspecific computer-based cognitive stimulation; it retrains brain networks through practice rather than using a drug. This is a non-drug, at-home program done over the internet and it does not replace or change levodopa or other anti-parkinsonian medications. Adults 18 to 100 with a clinical diagnosis of Parkinson's, on anti-parkinsonian treatment, with impaired working memory on the CABPad test (5 symbols or less backwards), internet access, and without Parkinson's dementia are eligible.
Locations
- Bispebjerg Hospital, Copenhagen, Denmark
- Rigshospitalet, Copenhagen, Denmark
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Computer-based cognitive rehabilitation (CBCR). The goal is to boost executive skills, especially working memory and everyday planning, that often decline in Parkinson's and cause real-life problems with thinking and multitasking. The approach is computer-assisted self-training made of repeated, adaptive exercises that target working memory, attention, and planning, compared with unspecific computer-based cognitive stimulation; it retrains brain networks through practice rather than using a drug. This is a non-drug, at-home program done over the internet and it does not replace or change levodopa or other anti-parkinsonian medications. Adults 18 to 100 with a clinical diagnosis of Parkinson's, on anti-parkinsonian treatment, with impaired working memory on the CABPad test (5 symbols or less backwards), internet access, and without Parkinson's dementia are eligible.
- Who can participate?
- Participants must be between 18 Years and 100 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 5 years and 7 months.